new_0222_0489|KNTE|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0489|KNTE|Long Name|1|1|Kinnate Biopharma Inc Total Current Assets (Quarterly) (USD)|Kinnate Biopharma Inc Cash and Short Term Investments (Quarterly) (USD)|Kinnate Biopharma Inc Inventories (Quarterly) (USD)|Kinnate Biopharma Inc Net PP&E (Quarterly) (USD)|Kinnate Biopharma Inc Goodwill and Intangibles (Quarterly) (USD)|Kinnate Biopharma Inc Total Liabilities (Quarterly) (USD)|Kinnate Biopharma Inc Total Current Liabilities (Quarterly) (USD)|Kinnate Biopharma Inc Total Long Term Liabilities (Quarterly) (USD)|Kinnate Biopharma Inc Total Deposits (Quarterly) (USD)|Kinnate Biopharma Inc Book Value (Quarterly) (USD)|Kinnate Biopharma Inc Retained Earnings (Quarterly) (USD)|Kinnate Biopharma Inc Treasury Stock (Quarterly) (USD)|Kinnate Biopharma Inc EV to Revenues|Kinnate Biopharma Inc EV to Earnings|Kinnate Biopharma Inc EV to Free Cash Flow|Kinnate Biopharma Inc EV to Assets (Quarterly)|Kinnate Biopharma Inc PS Ratio|Kinnate Biopharma Inc PE Ratio|Kinnate Biopharma Inc Price to Book Value|Kinnate Biopharma Inc PEG Ratio|Kinnate Biopharma Inc Debt to Equity Ratio|Kinnate Biopharma Inc Dividend Yield|Kinnate Biopharma Inc Shareholder Yield (TTM)|Kinnate Biopharma Inc Percent of Shares Outstanding Short|Kinnate Biopharma Inc Total Receivables (Quarterly) (USD)|Kinnate Biopharma Inc Total Payables (Quarterly) (USD)|Kinnate Biopharma Inc Total Capital Stock (Quarterly) (USD)|Kinnate Biopharma Inc Return on Invested Capital|Kinnate Biopharma Inc Quality Ratio Score|Kinnate Biopharma Inc Momentum Score|Kinnate Biopharma Inc Beta (1Y)|Kinnate Biopharma Inc Sustainable Growth Rate (TTM)|Kinnate Biopharma Inc Institutional Investor Ownership Percentage|Kinnate Biopharma Inc Average Diluted Shares Outstanding (Quarterly)|Kinnate Biopharma Inc Total Employees (Annual)|Kinnate Biopharma Inc EPS Diluted (Quarterly) (USD)|Kinnate Biopharma Inc SG&A Expense (Quarterly) (USD)|Kinnate Biopharma Inc Shares Outstanding|Kinnate Biopharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Kinnate Biopharma Inc Ordinary Shares Number (Quarterly)|Kinnate Biopharma Inc Payout Ratio|Kinnate Biopharma Inc Quick Ratio (Quarterly)|Kinnate Biopharma Inc Normalized Diluted EPS (Quarterly) (USD)|Kinnate Biopharma Inc Stock Buybacks (Quarterly) (USD)|Kinnate Biopharma Inc Effective Tax Rate (TTM)|Kinnate Biopharma Inc Return on Equity|Kinnate Biopharma Inc Net Income (TTM) (USD)|Kinnate Biopharma Inc Revenue (TTM) (USD)|Kinnate Biopharma Inc Dividend Per Share (Quarterly) (USD)|Kinnate Biopharma Inc Revenue (Quarterly) (USD)|Kinnate Biopharma Inc Gross Profit (Quarterly) (USD)|Kinnate Biopharma Inc Pre-Tax Income (Quarterly) (USD)|Kinnate Biopharma Inc Net Income (Quarterly) (USD)|Kinnate Biopharma Inc Net Interest Income (Quarterly) (USD)|Kinnate Biopharma Inc Price (USD)|Kinnate Biopharma Inc Total Return Price (USD)|Kinnate Biopharma Inc Enterprise Value (USD)|Kinnate Biopharma Inc 30-Day Average Daily Volume|Kinnate Biopharma Inc 1 Year Price Returns (Daily)|Kinnate Biopharma Inc Short Interest|Kinnate Biopharma Inc PE Ratio (Forward)|Kinnate Biopharma Inc PE Ratio (Forward 1y)|Kinnate Biopharma Inc PS Ratio (Forward)|Kinnate Biopharma Inc PS Ratio (Forward 1y)|Kinnate Biopharma Inc Quarterly EPS Estimates (USD)|Kinnate Biopharma Inc Quarterly Revenue Estimates (USD)|Kinnate Biopharma Inc Quarterly EPS Surprise|Kinnate Biopharma Inc Quarterly Revenue Surprise|Kinnate Biopharma Inc Quarterly Actual EPS (USD)|Kinnate Biopharma Inc Quarterly Actual Revenue (USD)|Kinnate Biopharma Inc Revenue Estimates for Current Fiscal Year (USD)|Kinnate Biopharma Inc Revenue Estimates for Next Fiscal Year (USD)|Kinnate Biopharma Inc Price Target (USD)|Kinnate Biopharma Inc Consensus Recommendation|Kinnate Biopharma Inc Price Target Num Estimates|Kinnate Biopharma Inc EPS Estimates for Current Fiscal Year (USD)|Kinnate Biopharma Inc EPS Estimates for Next Fiscal Year (USD)|Kinnate Biopharma Inc Research and Development Expense (Quarterly) (USD)|Kinnate Biopharma Inc Reconciled Depreciation (Quarterly) (USD)|Kinnate Biopharma Inc Non-Operating Interest Expense (Quarterly) (USD)|Kinnate Biopharma Inc Land and Improvements (Quarterly) (USD)|Kinnate Biopharma Inc Buildings and Improvements (Quarterly) (USD)|Kinnate Biopharma Inc Other Properties (Quarterly) (USD)|Kinnate Biopharma Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0489|KNTE|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0489|KNTE||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|monthly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0489|KNTE||5|5|127.8|127.8|0|127.8|0|127.8|127.8|127.8|0|127.8|127.8|0|0|0|1.44755244755|0|0|0|1.44918032787|0|0|1.44918032787|0|15.2592592593|183|127.8|127.8|0|0|0|31|0|0|91.2857142857|92|91.2857142857|91.2857142857|31.0909090909|0|127.8|0|0|91.2857142857|91.4|0|0|91.25|0|0|0|0|91.2857142857|91.2857142857|91.2857142857|1.44918032787|1.44918032787|1.44918032787|1.44565217391|1.45283018868|15.2592592593|0|0|0|0|91.25|91.25|91.5|0|91.5|91.5|37|40.7|40.7|21.4210526316|40.7|33.9166666667|37|91.2857142857|91.2857142857|0|0|0|0|127.8
new_0222_0489|KNTE||6|6|5|5|0|5|0|5|5|5|0|5|5|0|0|0|286|0|0|0|305|0|0|305|0|27|2|5|5|0|0|0|1|0|0|7|1|7|7|11|0|5|0|0|7|5|0|0|4|0|0|0|0|7|7|7|305|305|305|276|53|27|0|0|0|0|8|8|2|0|2|2|11|10|10|19|10|12|11|7|7|0|0|0|0|5
new_0222_0489|KNTE||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0489|KNTE|201912|201912|201912|77.451|76.453||0.154||95.091|1.945|93.146||-17.486|-17.568||||||||||||||0.973|0.956|0|||||||23.2827||-0.1693|0.926|||41.0272|||-0.1693|||||||||-3.942|-3.942|0.043||||||||||||||||||||||||3.059|0|||||0.154
new_0222_0489|KNTE|202003|202003|202003||||||||||||||||||||||||||||||||||23.2827||-0.1693|0.955||||||-0.1693|||||||||-3.941|-3.941|0.212||||||||||||||||||||||||3.198|0.016|||||
new_0222_0489|KNTE|202006|202006|202006||||||||||||||||||||||||||||||||||23.2827||-0.327|2.047||||||-0.327|0||||||||-7.614|-7.614|0.012||||||||||||||||||||||||5.579|0.02|||||
new_0222_0489|KNTE|202009|202009|202009|157.479|156.859||0.316||6.699|6.699|0||152.498|-39.622|0.075|||||||||||||0|2.328|0.003|||||||41.0272|27|-0.2559|2.019|||41.0272|||-0.2559|0|||-25.996|||||-10.499|-10.499|0.004||||||||||||||||||||||||8.484|0.023|||||0.375
new_0222_0489|KNTE|202012|202012|202012|400.203|396.86||0.368||7.304|7.304|0||393.267|-53.329||||-43.7257||||4.3979|||0||1.2611|0|3.94|0.004|||||||43.4774|31|-0.3153|1.743|43.4774||43.4774|||-0.3153|-253.314|||-35.761|||||-13.707|-13.707|0.017|39.78|39.78|1332.671|||548291|||||-0.3333|0|||||0|0|52|1.5|4|-1.45|-1.7467|11.976|0.024|||||0.451
new_0222_0489|KNTE|202101|202012|202012|||||||||||||||-33.7686||||3.6262|||0||1.1168|||||||||||||||||||||||||||||||32.8|32.8|1029.1987|158883.6||485564||||||||||||||||||||||||
new_0222_0489|KNTE|202102|202012|202012|||||||||||||||-34.6673||||3.6958|||0||2.1337|||||||||||||||||||||||||||||||33.43|33.43|1056.5895|115075.9||927663||||||||||||||||||||||||
new_0222_0489|KNTE|202103|202103|202103|251.172|248.197||0.283||7.793|7.793|0||378.572|-70.786||||-26.8445||||3.5786|||0||3.3334||3.212|0.004|||||||43.4774||-0.4|4.815|43.4774||43.4774|||-0.4||||-49.277|||||-17.457|-17.457|0.403|31.16|31.16|1106.5588|321891.5333||1449257|||||-0.33|0|-21.2121||-0.4|0|0|0|52.5|1.5|4|-1.7333|-2.4833|12.666|0.031|||||0.37
new_0222_0489|KNTE|202104|202103|202103|||||||||||||||-22.2731||||3.0808|||0||3.8703||||||||||||||43.4868|||||||||||||||||26.82|26.82|918.119|237389.8||1683051|||||||||||0|0|50|1.3333|3|||||||||
new_0222_0489|KNTE|202105|202103|202103|||||||||||||||-18.7596||||2.6983|||0||4.4465||||||||||||||43.5045|||||||||||||||||23.48|23.48|773.2887|139010.2667||1934438|||||||||||0|0|51|1.5|4|-1.9233|-2.73|||||||
new_0222_0489|KNTE|202106|202106|202106|258.78|220.008||0.286||43.323|8.323|35||361.34|-92.231||||-15.0389||||2.8105|||0||3.5817||1.334|0.004|||||||43.5359||-0.49|5.327|43.6227||43.6227|||-0.49|-0.495|||-63.108|||||-21.445|-21.445|0.672|23.28|23.28|795.5285|128192.1333||1562424|||||-0.4225|0|-15.9763||-0.49|0||||||||16.242|0.028|||||0.402
new_0222_0489|KNTE|202107|202106|202106|||||||||||||||-13.637||||2.6052|||0||3.6449|||||||||||||||||||||||||||||||21.58|21.58|721.3699|187471.4333||1589993||||||||||||||1.4||-1.8825|-2.5625|||||||
new_0222_0489|KNTE|202108|202106|202106|||||||||||||||-14.1046||||2.6737|||0||4.2114||||||||||||||43.676|||||||||||||||||22.12|22.12|746.1051|251258.4||1839375|||||||||||0|0|51|1.4|4|-1.9975|-2.58|||||||
new_0222_0489|KNTE|202109|202109|202109|260.712|223.228||0.291||45.299|10.299|35||341.03|-116.933||||-12.5529||||2.9486|||0||4.5967||2.724|0.004|||||||43.664||-0.57|6.073|43.6827||43.6827|||-0.57|0|||-77.311|||||-24.702|-24.702|0.64|23.02|23.02|782.3478|198007.9||2007944|||||-0.535|0|-6.5421||-0.57|0|0|0|47|1.2857|6|-2.0633|-2.4683|18.729|0.028|||||0.435
new_0222_0489|KNTE|202110|202109|202109|||||||||||||||-13.0786||||3.0447|||0||4.5376|||||||||||||||||||||||||||||||23.77|23.77|815.1098|81395.8333||1982136||||||||||||||1.2857||-2.0633|-2.4683|||||||
new_0222_0489|KNTE|202111|202109|202109|||||||||||||||-10.4265||||2.56|||0||3.9012||||||||||||||43.6961|||||||||||||||||19.98|19.98|649.8201|85360.9333||1704671|||||||||||0|0|47.5|1.2857|6|-1.9883|-2.4633|||||||
new_0222_0489|KNTE|202112|202112|202112|||||||||||||||-8.842||||2.2705|||0||3.9612|||||||0.2172||||||||||||||||||||||||17.72|17.72|551.0669|115861.9|-55.455|1730899|||||-0.575|0|||||0|||||-1.9917||||||||
new_0222_0489|KNTE|202201|202112|202112|||||||||||||||-4.1165||||1.4069|||0||4.3271||||||2|1.3939||||||||||||||||||||||||10.98|10.98|256.5552|126607.1333|-66.5244|1890774|||||||||||||47.5714|1.2857|7|-2.47|-2.86|||||||
new_0222_0489|KNTE|202202|202112|202112|||||||||||||||-2.7283||||1.1532|||0|||||||||||||||||||||||||||||||||9|9|170.0369|164589.2|-72.9973||||||||||||0|0|44.8571|1.2857|7|-2.51|-2.926|||||||
new_0222_0489|KNTE|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.584|0||||||||||||||||||
new_0222_0489|KNTE|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.624|0||||||||||||||||||
new_0222_0489|KNTE|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.668|0||||||||||||||||||
new_0222_0489|KNTE|202212|202212|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.755|0||||||||||||||||||